Patent · US Active

Antibodies with modulated glycan profiles

US12084686B2 · kind B2 · utility

0Cited by
25References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2019
Grant dateSep 10, 2024
Priority date—
Expiry dateSep 23, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2500/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to recombinantly-expressed denosumab molecules and methods for modulating glycan profiles of denosumab molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.